Semax
A synthetic ACTH-derived peptide studied extensively for cognitive, neuroprotective, and nootropic effects. Semax is researched for its role in memory, focus, and neurotrophic factor expression.
Four decades of cognitive research.
Semax is a synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH 4-10), developed alongside Selank at Russia’s Institute of Molecular Genetics and stabilized with the same protective tripeptide tail. The modification strips away ACTH’s hormonal activity while preserving central nervous system effects that have made it one of the most studied nootropic peptides to come out of Russian pharmacology.
Mental clarity is easy to take for granted until it slips, the fog that creeps in after a poor night’s sleep, the focus that frays under sustained stress. Semax research has centered on exactly that territory: memory, attention, and the brain’s capacity to recover from strain.
Published research has documented Semax’s role in increasing BDNF and NGF expression, supporting dopaminergic and serotonergic signaling, and demonstrating neuroprotective effects in models of ischemic stroke and oxidative neuronal stress. It has been studied clinically in Russia since the 1980s for cognitive and neurological applications.
Clarity, studied at the source.
Cognitive & Nootropic Research
Neurotrophic Factor Expression
Neuroprotective Research
